The unique way this virus sneaks into a cell’s nucleus could advance the study of cancer-causing pathogens

The finding could help scientists figure out a mystery of basic cell biology, as well.

10:00 AM

Author | Kelly Malcom

cancer cell nucleus virus orange pink
Justine Ross, Michigan Medicine

Viruses are tiny packets of destruction and there are more of them than any other biological entity on the planet.

Luckily, only a few hundred are known to make people sick, and figuring out what makes those viruses tick can help prevent illness. What's more, examining the way viruses have evolved to infect mammals can perhaps even answer basic questions about human health.

A study from a team at U-M Medical School takes a closer look at a virus that causes tumors in monkeys, called SV40. SV40 is a DNA virus that, in order to make more of itself, burrows into a cell and then into its nucleus, thereby infecting it.

"SV40 is used as a tool for understanding how viruses that cause cancer in humans work," said Chelsey Spriggs, Ph.D., assistant professor, Cell & Developmental Biology and Microbiology & Immunology at U-M Medical School, Research Assistant Professor at the U-M Life Sciences Institute, and first author of the study. Several viruses have been tied to cancer in people, including human papillomavirus, Kaposi Sarcoma-associated Herpesvirus and Epstein-Barr virus.

The study team wanted to more fully understand how this infection process happens inside the cell. An earlier study from Spriggs (at the time a postdoctoral fellow in the lab of Billy Tsai, Ph.D., the Corydon Ford Collegiate Professor of Cell & Developmental Biology), and their team found that SV40 travels from the surface of the cell, through the endosome, the endoplasmic reticulum and then to the cytosol where it is partially disassembled. The latest study illuminates the final and most important step for infection, entry into the nucleus.

The virus itself is bigger than the portal it uses to gain entry into a cell's nucleus, explained Spriggs, called the nuclear pore complex. The nuclear pore complex is a major port in the membrane of the nucleus, regulating the transport of proteins, RNA and other cellular cargo from the nucleus into the cell's cytoplasm and back again. Many viruses exploit this passageway to sneak into the nucleus.

The new study found that SV40 uses the nuclear pore complex and another protein complex called LINC, which connects the inner and outer membranes of the nucleus, first disassembling itself into a smaller package made up of two proteins and the virus' genome. Unlike many other viruses that grab onto fingerlike projections sticking out from the nuclear pore complex, SV40 interacts with LINC first before entering it.

This difference in technique might underlie SV40's ability to cause cancer, Spriggs notes. Further research into how SV40 exploits LINC and the nuclear pore complex could even help scientists understand how the two important cellular membrane complexes interact with each other, which so far is somewhat of a mystery.

"Viruses use a lot of the same pathways that are disrupted in cancers and other diseases," said Spriggs. "Studying them is good for understanding human biology."

Spriggs recently opened her own independent research lab at the University of Michigan studying the entry mechanism of human oncogenic viruses.

Additional authors on this paper include Grace Cha and Jiaqian Li.

Paper cited: "Components of the LINC and NPC complexes coordinately target and translocate a virus into the nucleus to promote infection," PLoS Pathogens. DOI: 10.1371/journal.ppat.1010824

Live your healthiest life: Get tips from top experts weekly. Subscribe to the Michigan Health blog newsletter

Headlines from the frontlines: The power of scientific discovery harnessed and delivered to your inbox every week. Subscribe to the Michigan Health Lab blog newsletter

Like Podcasts? Add the Michigan Medicine News Break on Spotify, Apple Podcasts or anywhere you listen to podcasts.


More Articles About: Lab Report Basic Science and Laboratory Research infectious disease Community Health Hospitals & Centers Wellness and Prevention Future Think All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Illustration of a microscope
Health Lab
Helpful enzymes vanish in many patients with antiphospholipid syndrome
Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.
Florescent image of a human ovarian follicle
Health Lab
Spatial atlas of the human ovary with cell-level resolution will bolster reproductive research
New map of the ovary provides a deeper understanding of how oocytes interact with the surrounding cells during the normal maturation process, and how the function of the follicles may break down in aging or fertility related diseases.
A CT scan of healthy lungs
Health Lab
Study reveals potential to reverse lung fibrosis using the body’s own healing technique
A recent U-M study uncovers a pathway utilized during normal wound healing that has the potential to reverse idiopathic pulmonary fibrosis.
Photo of a cluttered, messy garage
Health Lab
Chemicals stored in home garages linked to ALS risk
A Michigan Medicine study finds that storing chemicals in a garage at home may associate with an increased risk of ALS.
Health Lab
How to protect your eyes during the total solar eclipse
A Michigan Medicine ophthalmologist and retinal surgeon shares advice for viewing the total solar eclipse safely, including what to look for in eye protection.
heart organ yellow blue
Health Lab
Around 10% of deaths from coronary stenting, balloon angioplasty are preventable
Around 10% of all deaths following percutaneous coronary intervention are potentially preventable, a study led by Michigan Medicine finds.